)
After closing the September series as the best so far in 2013, where the Nifty rallied 9 percent, the October series is likely to open on a flat to positive note.
Early indicator, SGX Nifty was marginally down 2 points at 5,943.
However, market experts have warned that Nifty may drift lower towards the 5,750 level.
Overnight, the S&P 500 and Dow snapped five-day losing streaks on Thursday on positive job market data but gains were limited as investors worried if Washington lawmakers would pass bills to avoid a government shutdown and possible U.S. debt default on time.
The Dow Jones industrial average was up 0.36 percent, at 15,328. The Standard & Poor's 500 Index was up 0.35 percent, at 1,699. The Nasdaq Composite Index was up 0.70 percent, at 3,787.
The dollar held firm in early Asian trade after U.S. jobless claims figures pointed to a improving labor market, reviving expectations of a reduction in U.S. monetary stimulus.
Lack of progress in budget and debt negotiations in Washington could also undermine investor risk appetite, capping gains in global shares.
Both Japanese shares and MSCI's broadest index of Asia-Pacific shares outside Japan were little changed in early trade.
Stocks to Watch
Strides Arcolab will be in spotlight as Generic drugmaker Mylan Inc has won U.S. antitrust approval to buy Agila, a unit of Strides Arcolab, subject to divesting some products.
Adani Enterprises will be under pressure as Australia's new government has ordered major coal and coal seam gas projects to seek national environmental approval.
Jet Airways continues to remain in news after the airline defaulted on lease rentals of its Boeing 737s.
Pharma firms Lupin, Ranbaxy under see a negative start after US-based Forest Laboratories Inc and Forest laboratories Holding along with Royalty Pharma filed lawsuits against several firms including Lupin and Ranbaxy for infringement of patents related to Savella.
